Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated 28 minutes ago
Merck KGaA pledges $50M to build new cardio biotech with eye to later acquisition
28 minutes ago
Merck KGaA has committed $50 million to build a new biotech with...
Big obesity bets and China's rise fuel potential $2T in 2032 drug sales: Evaluate
about 2 hours ago
While dealmaking and investment dollars may be flowing across biopharma once again...
Corxel gears up for global pivotal push after oral GLP-1 posts ‘competitive’ ph. 2 results
about 3 hours ago
With a balance of competitive efficacy and tolerability, Corxel figures it has...
FDA issues early alert for J&J’s Abiomed catheter introducer over bleeding risk
about 3 hours ago
The FDA has sent out an early alert to J&J’s Abiomed unit...
Pfizer’s first new ADC from Seagen acquisition fails phase 3 NSCLC trial
about 3 hours ago
Pfizer announced Monday that sigvotatug vedotin, the first new ADC to read...
Exelixis’ Cabometyx successor fails primary endpoint in colorectal cancer trial amid FDA review
about 19 hours ago
Exelixis’ next franchise in a drug, zanzalintinib, has hit a clinical setback...
Federal health agencies unveil plan to speed up phase 1 clinical trials by 6 to 12 months
about 22 hours ago
As the biotech world flocks to San Diego today for the BIO...
Rethinking controls: The rise of VCGs in drug development
1 day ago
Virtual control groups are redefining study design—cutting animal use while advancing rigor...
In another reversal for rare disease field, FDA to reconsider Regenxbio gene therapy
1 day ago
In another sign that the FDA is easing its stance toward rare...
Merck’s anti-TL1A antibody from Prometheus buyout passes ph. 3 test in ulcerative colitis
1 day ago
Merck is making advances in the lucrative ulcerative colitis field with the...
Sanofi, Pangaea ink AI partnership deal to detect underdiagnosed genetic disease
1 day ago
French biopharma Sanofi inked a partnership deal with Pangaea Data to use...
AbbVie inks $10.9B Apogee buyout to bag hotly tipped eczema prospect
1 day ago
AbbVie has struck a deal to buy Apogee Therapeutics for $10.9 billion...